about
Amplification of autoimmune disease by infectionBaculovirus-mediated promoter assay and transcriptional analysis of white spot syndrome virus orf427 gene.Mutual Interference between Cytomegalovirus and Reconstitution of Protective Immunity after Hematopoietic Cell TransplantationBioactive Molecules Released From Cells Infected with the Human CytomegalovirusViral Subversion Mechanisms in Chronic Kidney Disease PathogenesisCytomegalovirus infection in immunocompetent critically ill adults: literature reviewAntiviral prevention of sepsis induced cytomegalovirus reactivation in immunocompetent mice.Biphasic recruitment of transcriptional repressors to the murine cytomegalovirus major immediate-early promoter during the course of infection in vivoHuman cytomegalovirus IE1 protein elicits a type II interferon-like host cell response that depends on activated STAT1 but not interferon-γAllogeneic stimulation causes transcriptional reactivation of latent murine cytomegalovirus.Characterization of cytomegalovirus disease in solid organ transplant recipients by markers of inflammation in plasma.Lipopolysaccharide, tumor necrosis factor alpha, or interleukin-1beta triggers reactivation of latent cytomegalovirus in immunocompetent miceCytomegalovirus reactivation in critically ill immunocompetent hosts: a decade of progress and remaining challenges.CD8 T cells control cytomegalovirus latency by epitope-specific sensing of transcriptional reactivationMitogen and stress activated kinases act co-operatively with CREB during the induction of human cytomegalovirus immediate-early gene expression from latency.Reversal of human cytomegalovirus major immediate-early enhancer/promoter silencing in quiescently infected cells via the cyclic AMP signaling pathway.Sociodemographic factors associated with IgG and IgM seroprevalence for human cytomegalovirus infection in adult populations of Pakistan: a seroprevalence survey.Transient CD8-memory contraction: a potential contributor to latent cytomegalovirus reactivation.An endogenous accelerator for viral gene expression confers a fitness advantage.Detection of oncogenic virus genomes and gene products in lung carcinomaTransplant-induced reactivation of murine cytomegalovirus immediate early gene expression is associated with recruitment of NF-κB and AP-1 to the major immediate early promoter.In vivo competence of murine cytomegalovirus under the control of the human cytomegalovirus major immediate-early enhancer in the establishment of latency and reactivation.Reconstitution of CD8 T Cells Protective against Cytomegalovirus in a Mouse Model of Hematopoietic Cell Transplantation: Dynamics and Inessentiality of Epitope Immunodominance.Epigenetic control of cytomegalovirus latency and reactivation.Disruption of murine cardiac allograft acceptance by latent cytomegalovirus.The mouse cytomegalovirus immediate-early 1 gene is not required for establishment of latency or for reactivation in the lungs.Liver sinusoidal endothelial cells are a site of murine cytomegalovirus latency and reactivationCytomegalovirus infection in critically ill patients: a systematic review.Role for tumor necrosis factor alpha in murine cytomegalovirus transcriptional reactivation in latently infected lungs.Evolving evidence implicates cytomegalovirus as a promoter of malignant glioma pathogenesis.Viral latency drives 'memory inflation': a unifying hypothesis linking two hallmarks of cytomegalovirus infection.The intimate relationship between human cytomegalovirus and the dendritic cell lineage.Tissue-specific control of latent CMV reactivation by regulatory T cells.Inflammasome expression and cytomegalovirus viremia in critically ill patients with sepsis.The Cell Biology of Cytomegalovirus: Implications for Transplantation.Cytomegalovirus reactivation in ICU patients.Nuclear factor kappa B is required for the production of infectious human herpesvirus 8 virions.A myeloid progenitor cell line capable of supporting human cytomegalovirus latency and reactivation, resulting in infectious progeny.The activator protein 1 binding motifs within the human cytomegalovirus major immediate-early enhancer are functionally redundant and act in a cooperative manner with the NF-{kappa}B sites during acute infectionVirus reactivation: a panoramic view in human infections
P2860
Q24804390-41AF6F49-6FA7-4591-98C6-9B3845DB82EAQ24814263-2B770A48-505A-490A-9E8D-57506A736262Q26740328-E925A424-0F31-402B-80D2-FA5F28F25A2AQ26744665-36FE8F73-12D1-44B8-8E0F-E8B3C94038FDQ27485200-8C3B91FF-B0EC-4437-BA30-1BAA72113255Q28079509-E995F615-D8E4-4EEC-82F6-3E3E6C080B48Q33695591-636E7A77-2B93-4DE5-82AC-D3B53ED88B14Q33725662-6977AEF7-B075-491C-A35B-2C8ABB76886AQ33886711-40CD0561-CEA1-47EF-8856-7FC54004970BQ34048734-327DF851-7B87-4084-9EEE-873F16D1915CQ34674064-2DB04BB4-9583-468A-AFC0-64C72BAF0445Q35024244-5CC2A253-D69A-4683-9656-60D372B817CBQ35086196-4CA2E6CF-343F-412D-8AF0-95FDFC951F2DQ35139332-067FD8AF-0A55-46B2-91C6-F9C290AE4C8CQ35191037-6CBBF34F-A920-46B8-867C-875CD2A3E32AQ35857316-36FAAB80-B8B8-4DAC-BC0D-389D09B9A6F5Q36172022-6574A6D6-8B07-4B47-95CC-46FBB489E2E2Q36332722-70FD252D-09CA-410A-9F87-12063B6FEF76Q36555148-E2B01966-89CE-4854-86F1-E1B6F54C295CQ36616275-D06E08E0-B77A-45E6-AEDB-3B6509424BC9Q36862292-B49F079E-AA0E-404F-9F2F-8F27D56B23CEQ36934017-C7620289-36A1-4B72-8E27-7BABEBCD8D4DQ36999665-BD2FAB98-A727-49FD-853B-A2FD5B600C29Q37015743-4F105152-846F-4519-A895-B67B0DB2B20AQ37060516-CCAFFA42-E3C7-40C7-B34F-424AA867C3C5Q37157169-B371E985-DB6B-44A4-8A80-0CBEBE2A2049Q37333761-907C6B65-6E05-4FB4-A7BF-705A70FFD9BAQ37482179-25BE30FD-8587-4177-A4DA-3DB6BAF89FD7Q37747368-DFF7DDED-F62C-40F9-8EA1-9EE87ECB99C6Q37949710-35FA85FB-EAF8-4E51-A58F-02126078DD65Q38044678-FA2D490B-ACA0-43B1-BCC2-B4FF243F53A3Q38242199-BF2FCB19-FBDB-4AC7-B888-505B138F1B4CQ38630384-F4C77992-872F-4579-A42C-16E7C1DBFF13Q38760428-0B1CD9D7-72C6-4142-AFB0-7045FEEEFAC7Q38779938-BE355FAA-DBD3-4653-8A91-50305D630E59Q38957959-FA0D14B8-0401-43EB-8220-FAAFE369D9FBQ39105335-409C9AA8-E777-4798-A866-0E72715EB039Q39320231-7EFC46A5-D8B2-4FE4-8FFC-36457BB94696Q39627859-ED8E9F17-9809-483B-B4D7-239165B3741EQ39723484-F3B00AA5-016D-4FAC-807D-E6C14A49D4AE
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
A model for reactivation of CMV from latency.
@ast
A model for reactivation of CMV from latency.
@en
A model for reactivation of CMV from latency.
@nl
type
label
A model for reactivation of CMV from latency.
@ast
A model for reactivation of CMV from latency.
@en
A model for reactivation of CMV from latency.
@nl
prefLabel
A model for reactivation of CMV from latency.
@ast
A model for reactivation of CMV from latency.
@en
A model for reactivation of CMV from latency.
@nl
P1476
A model for reactivation of CMV from latency.
@en
P2093
Mary Hummel
Michael M Abecassis
P304
P356
10.1016/S1386-6532(02)00088-4
P478
25 Suppl 2
P577
2002-08-01T00:00:00Z